story of the week
Estriol Vaginal Gel in HR+ Postmenopausal Women With Early-Stage Breast Cancer Treated With Nonsteroidal AIs
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Oncologist
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Phase II Prospective, Randomized, Double-Blind, Placebo-Controlled and Multicenter Clinical Trial to Assess the Safety of 0.005% Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women With Early Stage Breast Cancer in Treatment With Aromatase Inhibitor in the Adjuvant Setting
Oncologist 2020 May 27;[EPub Ahead of Print], P Sánchez-Rovira, AL Hirschberg, M Gil-Gil, B Bermejo-De Las Heras, C Nieto-MagroFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.